IPO-bound firms are adopting divergent listing strategies amid a volatile stock market. Companies needing fresh capital for expansion are proceeding, while those with offers for sale are reassessing plans, with at least five firms slowing or pausing their IPOs due to market headwinds and valuation concerns.
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812